ZA985136B - Pharmaceutical aerosol composition - Google Patents

Pharmaceutical aerosol composition

Info

Publication number
ZA985136B
ZA985136B ZA985136A ZA985136A ZA985136B ZA 985136 B ZA985136 B ZA 985136B ZA 985136 A ZA985136 A ZA 985136A ZA 985136 A ZA985136 A ZA 985136A ZA 985136 B ZA985136 B ZA 985136B
Authority
ZA
South Africa
Prior art keywords
aerosol composition
pharmaceutical aerosol
pharmaceutical
composition
aerosol
Prior art date
Application number
ZA985136A
Other languages
English (en)
Inventor
David Lewis
David Randerton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA985136(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of ZA985136B publication Critical patent/ZA985136B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA985136A 1997-06-13 1998-06-12 Pharmaceutical aerosol composition ZA985136B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (1)

Publication Number Publication Date
ZA985136B true ZA985136B (en) 1999-01-07

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985136A ZA985136B (en) 1997-06-13 1998-06-12 Pharmaceutical aerosol composition

Country Status (44)

Country Link
EP (2) EP0920302B2 (da)
JP (1) JP4380802B2 (da)
KR (1) KR100546239B1 (da)
CN (1) CN1138532C (da)
AR (1) AR012977A1 (da)
AT (1) ATE222751T1 (da)
AU (1) AU729966B2 (da)
BG (1) BG63906B1 (da)
BR (1) BR9805993B1 (da)
CA (1) CA2263445C (da)
CO (1) CO4940408A1 (da)
CZ (1) CZ295521B6 (da)
DE (1) DE69807420T3 (da)
DK (1) DK0920302T4 (da)
DZ (1) DZ2516A1 (da)
EA (1) EA001259B1 (da)
EE (1) EE03664B1 (da)
ES (1) ES2182351T5 (da)
GB (1) GB2326334A (da)
GE (1) GEP20012462B (da)
HR (1) HRP980317B1 (da)
HU (1) HU228487B1 (da)
ID (1) ID21491A (da)
IL (1) IL128484A (da)
IN (1) IN189317B (da)
IS (1) IS2435B (da)
IT (1) IT1293803B1 (da)
MA (1) MA26507A1 (da)
ME (2) MEP44008A (da)
MY (1) MY119074A (da)
NO (1) NO327775B1 (da)
NZ (1) NZ334149A (da)
PL (1) PL193721B1 (da)
PT (1) PT920302E (da)
RS (1) RS51274B (da)
SA (1) SA98190821B1 (da)
SI (1) SI0920302T2 (da)
SK (1) SK284430B8 (da)
TN (1) TNSN98087A1 (da)
TR (1) TR199900288T1 (da)
TW (1) TW555570B (da)
UA (1) UA70289C2 (da)
WO (1) WO1998056349A1 (da)
ZA (1) ZA985136B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
CA2317999C (en) 1999-09-11 2004-11-09 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
EP1523976A3 (en) * 1999-11-23 2005-06-22 Glaxo Group Limited Pharmaceutical formulations of salmeterol
EP1248597B1 (en) * 1999-12-24 2005-03-30 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
JP5392880B2 (ja) 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
IL163843A0 (en) 2002-03-01 2005-12-18 Chiesi Farma Spa Formoterol superfine formulation
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
EP1369113B1 (en) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Solubilisation of drugs in HFA propellant by means of emulsions
WO2004071488A1 (en) * 2003-02-04 2004-08-26 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
ME00420B (me) * 2003-03-20 2011-12-20 Boehringer Ingelheim Pharmaceuticals Inc Formulacija, za inhalator u kojem se odmjerava doza, u kojoj se kao propelenti koriste hidro-fluoro-alkani
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
BRPI0512878A (pt) 2004-07-02 2008-04-15 Boehringer Ingelheim Int formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
US20110105449A1 (en) * 2007-11-07 2011-05-05 Astrazeneca R&D Dry powder formulations comprising ascorbic acid derivates
CN105854136A (zh) * 2010-09-06 2016-08-17 奇斯药制品公司 计量剂量吸入器和使用该计量剂量吸入器的方法
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
EP2819669B1 (de) 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
WO2017167737A1 (en) 2016-03-31 2017-10-05 Chiesi Farmaceutici S.P.A. Aerosol inhalation device
AU2017328908B2 (en) * 2016-09-19 2020-04-02 Mexichem Fluor S.A. De C.V. Pharmaceutical composition
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU597049B2 (en) † 1986-03-10 1990-05-24 Kurt Burghart Pharmaceutical preparation containing nifedipine
WO1987005210A1 (fr) † 1986-03-10 1987-09-11 Kurt Burghart Produit pharmaceutique et son procede de preparation
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
AU658854B2 (en) † 1990-10-18 1995-05-04 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DK1277467T3 (da) † 1991-06-10 2007-01-15 Schering Corp Formuleringer af ikke-chlorfluorcarbonaerosoler
ES2200771T3 (es) † 1991-06-10 2004-03-16 Schering Corporation Formulaciones en aerosol no clorofluorocarbonadas.
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
DK0617610T3 (da) * 1991-12-18 1997-10-06 Minnesota Mining & Mfg Suspensionsaerosolformuleringer.
EP0673240B1 (en) * 1992-12-09 1999-03-24 Boehringer Ingelheim Pharmaceuticals Inc. Stabilized medicinal aerosol solution formulations
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
JP3911290B2 (ja) † 1994-05-13 2007-05-09 アラダイム コーポレーション エアゾールを含む麻酔用処方
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
JP2001505171A (ja) † 1996-12-04 2001-04-17 バイオグラン アイルランド（アール アンド ディ）リミテッド 製薬組成物及びその投与のための装置
DK1014943T3 (da) † 1997-02-05 2002-10-14 Jago Res Ag Medicinske aerosolformuleringer

Also Published As

Publication number Publication date
TW555570B (en) 2003-10-01
EP1219293A3 (en) 2003-05-28
EA199900201A1 (ru) 1999-06-24
BR9805993B1 (pt) 2009-05-05
EP0920302B2 (en) 2006-06-21
YU6999A (sh) 2000-03-21
SI0920302T2 (sl) 2006-10-31
ES2182351T5 (es) 2007-03-16
IL128484A (en) 2004-09-27
SK284430B8 (sk) 2005-05-05
CN1138532C (zh) 2004-02-18
HRP980317A2 (en) 1999-04-30
DE69807420T3 (de) 2006-11-16
EP0920302B1 (en) 2002-08-28
DE69807420T2 (de) 2003-05-08
HRP980317B1 (en) 2002-06-30
ID21491A (id) 1999-06-17
CZ46299A3 (cs) 1999-07-14
CN1229355A (zh) 1999-09-22
PT920302E (pt) 2002-11-29
AU729966B2 (en) 2001-02-15
MEP44008A (hr) 2011-02-10
CZ295521B6 (cs) 2005-08-17
IS4974A (is) 1999-02-11
DE69807420D1 (de) 2002-10-02
CA2263445A1 (en) 1998-12-17
JP2000516965A (ja) 2000-12-19
DZ2516A1 (fr) 2004-11-08
AR012977A1 (es) 2000-11-22
GB2326334A (en) 1998-12-23
TR199900288T1 (xx) 1999-09-21
KR100546239B1 (ko) 2006-01-26
NO990594D0 (no) 1999-02-09
NZ334149A (en) 2000-07-28
BG103221A (bg) 1999-09-30
PL193721B1 (pl) 2007-03-30
MA26507A1 (fr) 2004-12-20
SK17699A3 (en) 1999-07-12
SI0920302T1 (sl) 2002-12-31
AU8626298A (en) 1998-12-30
ME00333B (me) 2011-02-10
DK0920302T4 (da) 2006-10-09
NO990594L (no) 1999-04-13
SK284430B6 (sk) 2005-04-01
HK1022271A1 (en) 2000-08-04
EP1219293A2 (en) 2002-07-03
CA2263445C (en) 2008-09-09
TNSN98087A1 (fr) 2005-03-15
GEP20012462B (en) 2001-06-25
IS2435B (is) 2008-10-15
GB9712434D0 (en) 1997-08-13
JP4380802B2 (ja) 2009-12-09
DK0920302T3 (da) 2002-12-23
IL128484A0 (en) 2000-01-31
SA98190821B1 (ar) 2006-11-19
HUP0001339A2 (hu) 2000-09-28
EA001259B1 (ru) 2000-12-25
BR9805993A (pt) 1999-08-31
MY119074A (en) 2005-03-31
ATE222751T1 (de) 2002-09-15
IN189317B (da) 2003-02-08
PL331531A1 (en) 1999-07-19
HUP0001339A3 (en) 2000-10-30
RS51274B (sr) 2010-12-31
EE9900055A (et) 1999-08-16
EE03664B1 (et) 2002-04-15
UA70289C2 (uk) 2004-10-15
HU228487B1 (en) 2013-03-28
EP0920302A1 (en) 1999-06-09
IT1293803B1 (it) 1999-03-10
CO4940408A1 (es) 2000-07-24
WO1998056349A1 (en) 1998-12-17
ES2182351T3 (es) 2003-03-01
ITMI971798A1 (it) 1999-01-28
NO327775B1 (no) 2009-09-21
KR20000068171A (ko) 2000-11-25
BG63906B1 (bg) 2003-06-30

Similar Documents

Publication Publication Date Title
IL128484A0 (en) Pharmaceutical aerosol composition
IL139087A0 (en) Pharmaceutical aerosol formulation
GB9706089D0 (en) Pharmaceutical composition
GB9727053D0 (en) Pharmaceutical compositions
IL133928A0 (en) Pharmaceutical composition containing peptichemio
GB9717444D0 (en) Pharmaceutical composition
HUP0002455A3 (en) Gastric-retained pharmaceutical composition
AP9901657A0 (en) Pharmaceutical compositions
GB9717428D0 (en) Pharmaceutical composition
GB9723985D0 (en) Pharmaceutical compositions
HUP0004669A3 (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
GB9717770D0 (en) Pharmaceutical composition
GB2321190B (en) Pharmaceutical composition
GB9921495D0 (en) Pharmaceutical compositions
GB9726781D0 (en) Pharmaceutical composition
GB9718270D0 (en) Pharmaceutical compositions
GB9712097D0 (en) Pharmaceutical composition
GB9717575D0 (en) Pharmaceutical composition
GB9715614D0 (en) Pharmaceutical composition
GB9727238D0 (en) Pharmaceutical composition
GB9710525D0 (en) Pharmaceutical composition
HU9701598D0 (en) Pharmaceutical composition
GB9702517D0 (en) Pharmaceutical composition
ZA981391B (en) Pharmaceutical composition